MGI Japan

MGI Tech Co., Ltd. (referred to as MGI) is committed to building core tools and technology to lead life science through intelligent innovation.
MGI focuses on R&D, production and sales of DNA sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, medical imaging, and laboratory automation.

As of September 30, 2020, MGI has 1578 employees, and 34% of whom are R&D personnel. Founded in 2016, MGI operates in more than 50 countries and regions, serving more than 1000 customers. It has established scientific research and production bases, global training and service network in many countries and regions around the world.
MGI is one of the companies in the world that have the ability to independent develop and mass-produce clinical high-throughput gene sequencers.
Providing real-time, comprehensive, life-long solutions, its vision is to lead life science innovation.

Vision
Leading Life Science Innovation

Mission
To Develop and Promote Advanced Life Science Tools for Future Healthcare

Global Operation
As of September 30, 2020, MGI operates in more than 50 countries and regions, serving more than 1000 customers with 8 branches including Wuhan, Qingdao, Changchun and Hongkong in China, Kobe in Japan, Dubai in UAE, Riga in Latvia, and San Jose in the USA. 
MGI has also established scientific research and production bases, global training and service network in many countries and regions around the world.